AlphAIalphai — Financial news for AI agents
citybuzz.coJUL 312 min read$DVLT

Datavault AI Schedules Q2 2026 Financial Results Call

Datavault AI Inc. (NASDAQ: DVLT) said it will release Q2 2026 financial results before market open on Aug. 19, 2026, followed by a conference call and webcast at 8:30 a.m. ET. CEO Nathaniel Bradley and CFO Brett Moyer will discuss quarterly results and business updates, including its Acoustic Sciences and Data Sciences platforms.

Original reporting
citybuzz.co
Published Jul 31, 2026, 4:37 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 7:45 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Datavault AI Schedules Q2 2026 Financial Results Call — source image
Source · citybuzz.co
Decision brief

The 30-second read

$DVLTNeutralMed
01

Why it matters

The main tradable element is the fixed earnings date, which can drive options implied volatility and pre-earnings positioning. However, the text does not include any new financial outcomes or guidance.

02

Market read

A scheduled earnings event for DVLT sets a near-term catalyst date, but the article itself contains no new performance data.

03

What to watch

Traders may also watch for any commentary on Web 3.0 expansion and the Acoustic Sciences and Data Sciences divisions, but those details are not included here.

Relevance 5/10Novelty 5/10Timing: Aug 19, 2026 pre-market earnings release and 8:30 a.m. ET call

Background

Datavault AI announced it will report Q2 2026 financial results before the market opens on Aug 19, 2026 and host a live webcast at 8:30 a.m. ET.

Company-level read

Ticker impact

$DVLTNeutralMedium confidence
Context

Datavault AI (DVLT) scheduled its Q2 2026 results call for Aug 19, 2026 before the market opens, with CEO and CFO updates.

Expected impact

Likely modest near-term volatility into Aug 19 as traders price Q2 performance and any strategic updates, but no new financial numbers are provided here.

Evidence & confidence

The article discloses the earnings release timing and management participation, but contains no Q2 metrics, guidance, or surprises.

Market effects

Sector

Highlights investor attention on AI data valuation and monetization platforms ahead of quarterly reporting.

Regional

No specific regional market impact beyond the company’s Philadelphia headquarters.

Global

Limited, as the disclosure is company-specific and does not reference global macro or cross-border transactions.

Counterpoint

What could challenge this read

Because the article provides no Q2 figures or guidance, the market may treat it as routine and focus only on the actual earnings release.

Key entities

  • company
    Datavault AI Inc.

    NASDAQ-listed AI-driven data valuation and monetization company scheduling its Q2 2026 results call.

  • executive
    Nathaniel Bradley

    CEO scheduled to discuss quarterly results and business updates on the earnings call.

  • executive
    Brett Moyer

    CFO scheduled to discuss quarterly results and business updates on the earnings call.

Read at source← All news

Related articles

AUG 7
$DVLTMed

Datavault AI Hit With Securities Lawsuit

Datavault AI Inc. (NASDAQ: DVLT) faces a new securities class action, according to DJS Law Group, alleging the company misled investors about operations, partnerships, and growth prospects. The proposed class period is Sept. 4, 2024 to Oct. 30, 2025. The claims stem largely from a Wolfpack Research report that preceded a ~19% one-day share drop. Lead plaintiff deadline is Oct. 5, 2026.

stl.news4 min
AUG 7
$DVLTMed

Pomerantz Law Firm Announces the Filing of a Class Action Against Datavault AI Inc. and Certain Officers - DVLT

Pomerantz LLP said it filed a securities class action against Datavault AI Inc. (NASDAQ: DVLT) and certain officers in the Eastern District of Pennsylvania, covering purchases from Sept. 4, 2024 to Oct. 30, 2025. The suit alleges misleading statements about partnerships, trading activity, and compliance. After a Wolfpack Research report on Oct. 31, 2025, DVLT shares fell 19.44% to $2.03.

prnewswire.com4 min
JUL 30
$DVLTMed

Datavault AI Expands Data Driven Outcome Healthcare

Datavault AI (NASDAQ:DVLT) said it amended its definitive agreement with DataMeds AI (NASDAQ:MEDS) to expand a PharmacyChain blockchain technology licensing relationship into unencumbered commercial healthcare, healthspan and wellness uses. Datavault AI will receive common shares worth about 19.9% of DataMeds’ stock at closing, replacing preferred shares for tax optimization.

natlawreview.com3 min
JUL 29
$MEDSMed

DataMEDS AI, Inc.: DataMeds AI Expands License with DataVault AI for Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License

DataMeds AI (NASDAQ:MEDS) said it amended its licensing agreement with Datavault AI (NASDAQ:DVLT) to expand PharmacyChain blockchain-related licensing from pharmaceutical distribution to all unencumbered commercial healthcare, healthspan and wellness uses. The deal is tied to a pending multi-party combination and includes DVLT receiving common shares worth about 19.9% of MEDS at closing.

finanznachrichten.de6 min